ArticleJournal of clinical medicine2026

Pharmacogenetics-Guided De-Escalation of Dual Antiplatelet Therapy Based on CYP2C19 Testing in Patients After Acute Coronary Syndrome: Clinical Outcomes and Cost-Consequence Analysis.

Firuz Kh Turaev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.